HK1204947A1 - Sterilized composition - Google Patents
Sterilized compositionInfo
- Publication number
- HK1204947A1 HK1204947A1 HK15105620.0A HK15105620A HK1204947A1 HK 1204947 A1 HK1204947 A1 HK 1204947A1 HK 15105620 A HK15105620 A HK 15105620A HK 1204947 A1 HK1204947 A1 HK 1204947A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sterilized composition
- sterilized
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01021—Beta-glucosidase (3.2.1.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Peptides Or Proteins (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Moulding By Coating Moulds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012110390 | 2012-05-14 | ||
| JP2012110765 | 2012-05-14 | ||
| JP2013040593 | 2013-03-01 | ||
| PCT/JP2013/063868 WO2013172468A1 (ja) | 2012-05-14 | 2013-05-13 | 滅菌組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1204947A1 true HK1204947A1 (en) | 2015-12-11 |
Family
ID=49583866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15105620.0A HK1204947A1 (en) | 2012-05-14 | 2015-06-15 | Sterilized composition |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10071061B2 (ja) |
| EP (1) | EP2851085B1 (ja) |
| JP (1) | JP5746430B2 (ja) |
| KR (1) | KR102037555B1 (ja) |
| CN (1) | CN104284673B (ja) |
| AU (1) | AU2013261308B2 (ja) |
| BR (1) | BR112014028443B1 (ja) |
| CA (1) | CA2873602C (ja) |
| DK (1) | DK2851085T3 (ja) |
| ES (1) | ES2746300T3 (ja) |
| HK (1) | HK1204947A1 (ja) |
| IN (1) | IN2014DN09621A (ja) |
| MX (1) | MX356545B (ja) |
| PL (1) | PL2851085T3 (ja) |
| PT (1) | PT2851085T (ja) |
| RU (1) | RU2695522C2 (ja) |
| TW (1) | TWI636799B (ja) |
| WO (1) | WO2013172468A1 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI584825B (zh) * | 2012-05-14 | 2017-06-01 | 帝人股份有限公司 | 薄片成形體及止血材 |
| EP3245871A1 (en) | 2014-04-30 | 2017-11-22 | Matoke Holdings Limited | Antimicrobial compositions |
| GB2550301B (en) * | 2015-02-03 | 2019-12-11 | Matoke Holdings Ltd | Antimicrobial fibers and compositions |
| GB201716986D0 (en) | 2017-10-16 | 2017-11-29 | Matoke Holdings Ltd | Antimicrobial compositions |
| WO2020158833A1 (ja) | 2019-01-31 | 2020-08-06 | セルメディシン株式会社 | 無機塩類タンパク複合医療機器 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2209937B (en) | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
| JPH0622570B2 (ja) * | 1989-01-31 | 1994-03-30 | 多木化学株式会社 | 生体材料 |
| CH679207A5 (ja) | 1989-07-28 | 1992-01-15 | Debiopharm Sa | |
| US5225205A (en) | 1989-07-28 | 1993-07-06 | Debiopharm S.A. | Pharmaceutical composition in the form of microparticles |
| US5439688A (en) | 1989-07-28 | 1995-08-08 | Debio Recherche Pharmaceutique S.A. | Process for preparing a pharmaceutical composition |
| CA2033046C (en) | 1990-01-12 | 1999-08-03 | Lowell Saferstein | Process for preparing a neutralized oxidized cellulose product and its method of use |
| AU663328B2 (en) | 1991-06-21 | 1995-10-05 | Genetics Institute, Llc | Pharmaceutical formulations of osteogenic proteins |
| CH683149A5 (fr) | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
| GB9206509D0 (en) | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges containing active agents |
| US5730933A (en) * | 1996-04-16 | 1998-03-24 | Depuy Orthopaedics, Inc. | Radiation sterilization of biologically active compounds |
| US5945128A (en) | 1996-09-04 | 1999-08-31 | Romano Deghenghi | Process to manufacture implants containing bioactive peptides |
| GB2344519B (en) | 1998-12-07 | 2004-05-19 | Johnson & Johnson Medical Ltd | Sterile therapeutic compositions |
| DK2079767T3 (da) | 2006-10-11 | 2014-10-27 | Tolmar Therapeutics Inc | Fremstilling af bionedbrydelige polyestere med lave burst-egenskaber ved ekstraktion med et superkritisk fluid |
| US8076448B2 (en) | 2006-10-11 | 2011-12-13 | Tolmar Therapeutics, Inc. | Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction |
| ATE530576T1 (de) * | 2007-08-01 | 2011-11-15 | Ethicon Inc | Collagen-assoziierte peptide und ihre verwendung |
| AR074603A1 (es) * | 2008-12-15 | 2011-01-26 | Novartis Ag | Formulacion de deposito de octreotida con niveles de exposicion constantemente altos.uso. metodo. kit |
| JP5658175B2 (ja) * | 2009-03-10 | 2015-01-21 | メドプリン リジェネラティブ メディカル テクノロジーズ カンパニーリミテッド | 人工硬膜及びその製造方法 |
| JP5555928B2 (ja) | 2009-08-28 | 2014-07-23 | 日本バイリーン株式会社 | 酵素含有ナノファイバーの製造方法、酵素含有ナノファイバー、この酵素含有ナノファイバーを含む不織布及びこの不織布を用いた反応装置 |
| JP5479584B2 (ja) * | 2010-05-07 | 2014-04-23 | 帝人株式会社 | 生体糊用補強材及びその製造方法 |
| US8273369B2 (en) * | 2010-05-17 | 2012-09-25 | Ethicon, Inc. | Reinforced absorbable synthetic matrix for hemostatic applications |
| EP2575775B1 (en) * | 2010-06-01 | 2018-04-04 | Baxter International Inc. | Process for making dry and stable hemostatic compositions |
| JP5792442B2 (ja) * | 2010-09-01 | 2015-10-14 | 帝人株式会社 | 細胞特異的ペプチドを含有する繊維構造体 |
-
2013
- 2013-05-13 KR KR1020147031717A patent/KR102037555B1/ko active IP Right Grant
- 2013-05-13 EP EP13791568.2A patent/EP2851085B1/en active Active
- 2013-05-13 US US14/400,732 patent/US10071061B2/en active Active
- 2013-05-13 JP JP2014515698A patent/JP5746430B2/ja active Active
- 2013-05-13 WO PCT/JP2013/063868 patent/WO2013172468A1/ja active Application Filing
- 2013-05-13 AU AU2013261308A patent/AU2013261308B2/en active Active
- 2013-05-13 RU RU2014150498A patent/RU2695522C2/ru active
- 2013-05-13 BR BR112014028443-1A patent/BR112014028443B1/pt active IP Right Grant
- 2013-05-13 IN IN9621DEN2014 patent/IN2014DN09621A/en unknown
- 2013-05-13 DK DK13791568.2T patent/DK2851085T3/da active
- 2013-05-13 PL PL13791568T patent/PL2851085T3/pl unknown
- 2013-05-13 CA CA2873602A patent/CA2873602C/en active Active
- 2013-05-13 TW TW102116959A patent/TWI636799B/zh active
- 2013-05-13 PT PT137915682T patent/PT2851085T/pt unknown
- 2013-05-13 CN CN201380025306.6A patent/CN104284673B/zh active Active
- 2013-05-13 MX MX2014013818A patent/MX356545B/es active IP Right Grant
- 2013-05-13 ES ES13791568T patent/ES2746300T3/es active Active
-
2015
- 2015-06-15 HK HK15105620.0A patent/HK1204947A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2014DN09621A (ja) | 2015-07-31 |
| EP2851085B1 (en) | 2019-06-26 |
| US20150125511A1 (en) | 2015-05-07 |
| AU2013261308B2 (en) | 2018-02-08 |
| JP5746430B2 (ja) | 2015-07-08 |
| RU2695522C2 (ru) | 2019-07-23 |
| DK2851085T3 (da) | 2019-09-09 |
| CA2873602A1 (en) | 2013-11-21 |
| CN104284673B (zh) | 2018-02-13 |
| JPWO2013172468A1 (ja) | 2016-01-12 |
| PL2851085T3 (pl) | 2019-12-31 |
| BR112014028443A8 (pt) | 2018-02-06 |
| EP2851085A4 (en) | 2015-04-15 |
| MX2014013818A (es) | 2015-05-11 |
| BR112014028443A2 (pt) | 2017-06-27 |
| TW201350147A (zh) | 2013-12-16 |
| TWI636799B (zh) | 2018-10-01 |
| KR20150023253A (ko) | 2015-03-05 |
| US10071061B2 (en) | 2018-09-11 |
| WO2013172468A1 (ja) | 2013-11-21 |
| KR102037555B1 (ko) | 2019-10-28 |
| EP2851085A1 (en) | 2015-03-25 |
| CN104284673A (zh) | 2015-01-14 |
| ES2746300T3 (es) | 2020-03-05 |
| CA2873602C (en) | 2022-08-16 |
| AU2013261308A1 (en) | 2014-12-04 |
| PT2851085T (pt) | 2019-10-11 |
| BR112014028443B1 (pt) | 2021-01-19 |
| RU2014150498A (ru) | 2016-07-10 |
| MX356545B (es) | 2018-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2897613A4 (en) | TREATMENT COMPOSITIONS | |
| GB2506426B (en) | Composition | |
| PL2804487T3 (pl) | Kompozycja | |
| HK1207989A1 (en) | Composition | |
| GB201218954D0 (en) | Composition | |
| GB2498803B (en) | Composition | |
| HRP20190326T1 (hr) | Pripravak | |
| ZA201500519B (en) | Composition | |
| HK1199198A1 (en) | Composition | |
| HK1204947A1 (en) | Sterilized composition | |
| EP2878295A4 (en) | COMPOSITION | |
| ZA201407419B (en) | Composition | |
| EP2837670A4 (en) | COMPOSITION CONTAINING FLUOROBIPHENYL | |
| GB201206035D0 (en) | Composition | |
| HK1210966A1 (en) | Misprostol composition | |
| HRP20190033T1 (hr) | Pripravak | |
| EP2910538A4 (en) | AGENT COMPOSITION GENERATING GAS | |
| EP2910537A4 (en) | AGENT COMPOSITION GENERATING GAS | |
| GB201209597D0 (en) | Composition | |
| GB201208133D0 (en) | Composition | |
| GB201311517D0 (en) | Composition | |
| GB201219383D0 (en) | Composition | |
| GB201218195D0 (en) | Composition | |
| HK1204230A1 (en) | Composition | |
| GB201223526D0 (en) | Composition |